Okay, let's tackle this question. The user provided a question about topical beta blockers for the eye OPD. The correct answer is missing, but the task is to create a detailed explanation once the correct answer is known.

First, the core concept here is the properties of topical beta blockers used in ophthalmology. These drugs are typically used for conditions like glaucoma. The key properties would include lipid solubility for corneal penetration, minimal systemic absorption, and the ability to cross the blood-aqueous barrier. Also, they should have a low risk of systemic side effects since they're applied topically.

The question asks which property the chosen drug should *not* have. So the correct answer is the one that's a disadvantage. Common beta blockers for the eye include timolol, betaxolol, and carteolol. They need to be lipid-soluble to enter the eye effectively. If a drug is highly water-soluble, it won't penetrate the cornea well, making it less effective. Also, drugs that are absorbed systemically might cause side effects like bradycardia or bronchospasm, so they should have low systemic absorption.

Now, looking at the options (even though they're not listed here), the incorrect options would include properties that are actually desirable. For example, high systemic absorption would be bad, but if an option says the drug should have high systemic absorption, that's the wrong one. Other wrong options might include things like high protein binding or long half-life, which might not be necessary for topical use.

The clinical pearl here is that topical beta blockers for glaucoma must be lipid-soluble to cross the cornea and reach the aqueous humor. High systemic absorption is a red flag because it leads to unwanted systemic effects. Students should remember that the goal is local action with minimal systemic exposure.

Putting this all together, the correct answer is the one that states the drug should have high systemic absorption. The explanation should cover why the other properties are necessary and why high systemic absorption is undesirable. Each incorrect option should be addressed for why they are actually correct properties except for the one that's not.

**Core Concept**
Topical beta blockers used in ophthalmology (e.g., for glaucoma) must have **lipid solubility** to cross the cornea, **low systemic absorption** to avoid adverse effects, and **minimal protein binding** to ensure efficacy. They should also avoid crossing the blood-brain barrier to prevent CNS toxicity.

**Why the Correct Answer is Right**
The correct answer is the property that the drug **should NOT** have. Beta blockers for glaucoma require **lipid solubility** to penetrate the cornea and reach the aqueous humor. High systemic absorption is undesirable, as it increases risks like bradycardia or bronchospasm. Additionally, drugs with a **short half-life** are preferred for localized action. The exception is **high systemic absorption**, which compromises safety and is actively avoided.

**Why Each Wrong Option is Incorrect**
**Option A:** *Lipid solubility* is correct because it enables corneal penetration.
**Option B:** *Low systemic absorption* is correct to minimize adverse effects.
**Option C:** *Minimal protein binding* is correct to ensure bioavailability at the target site.

**Clinical Pearl / High

✓ Correct Answer: A. Strong local anaesthetic activity